Detalles de la búsqueda
1.
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testing.
Biotechnol Bioeng
; 121(1): 131-138, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855050
2.
SARS-CoV-2 and the safety margins of cell-based biological medicinal products.
Biologicals
; 68: 122-124, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891497
3.
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice.
Virol J
; 11: 70, 2014 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24739285
4.
Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza.
Transfusion
; 52(4): 803-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21981280
5.
Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines.
Hum Vaccin Immunother
; 9(6): 1333-45, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857272
6.
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
Vaccine
; 30(31): 4625-31, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22580355
7.
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
PLoS One
; 5(8): e12217, 2010 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20808939
8.
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
PLoS One
; 5(2): e9349, 2010 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20186321
Resultados
1 -
8
de 8
1
Próxima >
>>